Correlation Between VistaGen Therapeutics and Elicio Therapeutics
Can any of the company-specific risk be diversified away by investing in both VistaGen Therapeutics and Elicio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VistaGen Therapeutics and Elicio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VistaGen Therapeutics and Elicio Therapeutics, you can compare the effects of market volatilities on VistaGen Therapeutics and Elicio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VistaGen Therapeutics with a short position of Elicio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of VistaGen Therapeutics and Elicio Therapeutics.
Diversification Opportunities for VistaGen Therapeutics and Elicio Therapeutics
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between VistaGen and Elicio is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding VistaGen Therapeutics and Elicio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elicio Therapeutics and VistaGen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VistaGen Therapeutics are associated (or correlated) with Elicio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elicio Therapeutics has no effect on the direction of VistaGen Therapeutics i.e., VistaGen Therapeutics and Elicio Therapeutics go up and down completely randomly.
Pair Corralation between VistaGen Therapeutics and Elicio Therapeutics
Given the investment horizon of 90 days VistaGen Therapeutics is expected to under-perform the Elicio Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, VistaGen Therapeutics is 2.0 times less risky than Elicio Therapeutics. The stock trades about -0.43 of its potential returns per unit of risk. The Elicio Therapeutics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 478.00 in Elicio Therapeutics on August 23, 2024 and sell it today you would earn a total of 34.00 from holding Elicio Therapeutics or generate 7.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
VistaGen Therapeutics vs. Elicio Therapeutics
Performance |
| Timeline |
| VistaGen Therapeutics |
| Elicio Therapeutics |
VistaGen Therapeutics and Elicio Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with VistaGen Therapeutics and Elicio Therapeutics
The main advantage of trading using opposite VistaGen Therapeutics and Elicio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VistaGen Therapeutics position performs unexpectedly, Elicio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elicio Therapeutics will offset losses from the drop in Elicio Therapeutics' long position.| VistaGen Therapeutics vs. ZyVersa Therapeutics | VistaGen Therapeutics vs. Sonnet Biotherapeutics Holdings | VistaGen Therapeutics vs. Zura Bio Limited | VistaGen Therapeutics vs. Phio Pharmaceuticals Corp |
| Elicio Therapeutics vs. ZyVersa Therapeutics | Elicio Therapeutics vs. Sonnet Biotherapeutics Holdings | Elicio Therapeutics vs. Zura Bio Limited | Elicio Therapeutics vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |